Funded by
the European Union

News

EuCARE Achieves Milestones in Patient Enrollment and Research

🌟 EuCARE Surpasses 50,000 Patient Milestone! The EuCARE initiative has reached a significant milestone, enrolling over 50,000 patients across its clinical cohorts. These cohorts include the Hospitalised cohort, focusing on patients with COVID-19, and the Post-COVID cohort (PASC), investigating long-term sequelae of the virus. Enrollment status for clinical studies 🔬 Unprecedented Progress in Research: EuCARE […]

EuCARE Achieves Milestones in Patient Enrollment and Research Read More »

EuCARE Partners Present Research Findings at CROI 2024

EuCARE partners made contributions to the Conference on Retroviruses and Opportunistic Infections 2024 (CROI), held from March 3rd to 6th, 2024. This prestigious conference, established in 1993, serves as a vital platform for basic scientists and clinical investigators to exchange insights into the epidemiology and biology of human retroviruses and associated diseases. Pontus Hegberg, a

EuCARE Partners Present Research Findings at CROI 2024 Read More »

New EuCARE publication in the Lancet Regional Health- Europe

This cohort study within the EuCARE project entitled: “In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project”, uses data from 38,585 adult patients hospitalised with SARS-CoV-2 Wild-type, Alpha, Delta, or Omicron infection across 10 centres in 9 countries: Germany, Italy, Kenya, Lithuania, Mexico, Poland, Portugal,

New EuCARE publication in the Lancet Regional Health- Europe Read More »

MiƂosz Parczewski appointed National Consultant for Infectious Diseases by Polish Minister of Health

On the past 21st of December 2023, MiƂosz Parczewski, EuCARE partner from the Pomeranian Medical University in Poland, was appointed National Consultant for Infectious Diseases by Polish Minister of Health. This achievement is an important recognition of Milosz important clinical and research work on Infectious Diseases and specially in Virology. MiƂosz Parczewski received the MD

MiƂosz Parczewski appointed National Consultant for Infectious Diseases by Polish Minister of Health Read More »

EuCARE results in the advertorial published on the pages of IL SOLE 24 ORE on 20-12-2023 in the Special: “Excellent realities”.

The EuCARE project was highlighted as an article in an important Italian newspaper, within the scope of a piece entitled: “What are the best actions to take in emergency situations” The article includes interventions from EuCARE members: Prof. Giulia Marchetti, Dr. Francesca Incardona, Prof Sara Gandini and Prof. Pietro Lopalco. Prof Giulia Marchetti underlines the

EuCARE results in the advertorial published on the pages of IL SOLE 24 ORE on 20-12-2023 in the Special: “Excellent realities”. Read More »

Giulia Marchetti invited to present at the European Medicines Agency Workshop!

Giulia Marchetti, from the ASST Santi Paolo e Carlo, one of the EuCARE partners, was invited to give a presentation about the “Update on the physiopathological mechanisms of Long-COVID: The role of viral/antigen persistence and links to possible therapeutic strategies” at EMA-Workshop on generating clinical evidence for treatment and prevention options for Long-COVID and Post-acute

Giulia Marchetti invited to present at the European Medicines Agency Workshop! Read More »

New publication on Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV!

This new study, with the participation of Alessandro Cozzi-Lepri from University College of London, was published yesterday in the Vaccines journal. The manuscript “Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV” analyses an observational cohort on the outcomes of COVID-19 mRNA vaccination in People living with HIV in a

New publication on Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV! Read More »

6 Key Take-Home Messages from the EuCARE ‘Joint Dialogue on Preparedness’ meeting 2023

Following up on our successful and profitable EuCARE ‘Joint Dialogue on Preparedness’ meeting, we are extremely happy to share with our partners and friends 6 take-home messages: 1. A strong evidence-base is essential for the design of successful and ethically acceptable non pharmacological interventions: epidemiological studies should be run quickly, complemented by other observational and randomised controlled studies,

6 Key Take-Home Messages from the EuCARE ‘Joint Dialogue on Preparedness’ meeting 2023 Read More »